Evidence map›Paper›PMID 32210575›Full record

ArticleOncoTargets and therapy2020

Prognostic Nomogram for Patients with Radical Surgery for Non-Metastatic Colorectal Cancer Incorporating Hematological Biomarkers and Clinical Characteristics.

Peiyun Long, Youya Zang, Huan Wang, Xiumei Liang, Xuekun Xie, Zhiwei Han, Dongyi Lin, Zongyu Wang, Shan Huang, Chuang Chen

Abstract read
In one paragraph

Article in OncoTargets and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Peiyun Long *Department of Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.ORCID 0000-0002-1554-4321
Youya Zang *Department of Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
Huan WangDepartment of Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.ORCID 0000-0002-2583-5317
Xiumei LiangDepartment of Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
Xuekun XieDepartment of Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
Zhiwei HanDepartment of Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.ORCID 0000-0002-2669-2354
Dongyi LinDepartment of Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.ORCID 0000-0001-9085-5210
Zongyu WangDepartment of Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
Shan HuangDepartment of Oncological Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
Chuang ChenDepartment of Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.ORCID 0000-0001-5367-4349

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a large difference in postoperative survival in patients with non-metastatic colorectal cancer. We aimed to develop nomograms incorporating both hematological biomarkers and clinical characteristics to predict overall survival (OS) in patients with radical surgery for non-metastatic colorectal cancer.

methodsA retrospective analysis was performed on date from 508 patients who underwent radical resection of colorectal cancer at the Affiliated Tumor Hospital of Guangxi Medical University from December 2011 to December 2015. Simple random sampling was performed by dividing these patients into a training set (n=355) and validation set(n=153), which yielded a 7:3 ratio in the sample sizes between these groups. Based on COX regression analysis of the results from the training cohort, a nomogram was developed to predict the three-year and five-year overall survival rate, and internal verification was also performed. The nomogram prediction accuracy and discriminating ability were evaluated by Harrell's C-index (C-index), calibration curves and were compared with the colorectal cancer TNM staging system.

resultsWe found that age, degree of differentiation, T stage, N stage, neurological invasion, neutrophils, monocytes, HGB, and LDH were independent risk factors for predicting OS in patients with colorectal cancer. In the training cohort, the C index was 0.796 (95% CI: 0.761-0.831). In the validation cohort, the C index was 0.671 (95% CI: 0.656-0.686).The nomogram showed a stronger predictive ability than did TNM staging. Decision curve analysis showed that the nomogram had value in terms of clinical application.

conclusionOur nomogram combined hematological biomarkers and clinical characteristics and was highly effective in predicting OS in patients with non-metastatic colorectal cancer. Hence, our nomogram may provide a reference tool for clinicians to guide individualized treatment and follow-ups for patients with colorectal cancer.

Indexed as

colorectal cancermortalitynomogramprognostic

Identifiers

PMID32210575
PMCPMC7069577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.